Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2015 | 06-2014 | |
| Operating Expenses | 2,016 | 908 |
| Operating Income | -2,016 | -908 |
| Other Income | -15 | -349 |
| Pre-tax Income | -2,031 | -1,257 |
| Net Income Continuous | -2,031 | -1,257 |
| Net Income | $-2,031 | $-1,257 |
| EPS Basic Total Ops | -0.07 | -0.06 |
| EPS Basic Continuous Ops | -0.07 | -0.06 |
| EPS Diluted Total Ops | -0.07 | -0.06 |
| EPS Diluted Continuous Ops | -0.07 | -0.06 |
| EBITDA(a) | $-2,009 | $-904 |